These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36851574)

  • 1. Establishing a New Platform to Investigate the Efficacy of Oncolytic Virotherapy in a Human Ex Vivo Peritoneal Carcinomatosis Model.
    Koch J; Beil J; Berchtold S; Mönch D; Maaß A; Smirnow I; Schenk A; Carter ME; Kloker LD; Leibold T; Renner P; Dahlke MH; Lauer UM
    Viruses; 2023 Jan; 15(2):. PubMed ID: 36851574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy using therapeutic and diagnostic recombinant oncolytic vaccinia virus GLV-1h153 for management of colorectal peritoneal carcinomatosis.
    Eveno C; Mojica K; Ady JW; Thorek DL; Longo V; Belin LJ; Gholami S; Johnsen C; Zanzonico P; Chen N; Yu T; Szalay AA; Fong Y
    Surgery; 2015 Feb; 157(2):331-7. PubMed ID: 25616946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Three-Dimensional Organoid Model of Primary Breast Cancer to Investigate the Effects of Oncolytic Virotherapy.
    Carter ME; Hartkopf AD; Wagner A; Volmer LL; Brucker SY; Berchtold S; Lauer UM; Koch A
    Front Mol Biosci; 2022; 9():826302. PubMed ID: 35223990
    [No Abstract]   [Full Text] [Related]  

  • 4.
    Giehl E; Kosaka H; Liu Z; Feist M; Kammula US; Lotze MT; Ma C; Guo ZS; Bartlett DL
    Front Immunol; 2021; 12():610042. PubMed ID: 33679747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Different Oncolytic Vaccinia Virus Strains for the Treatment of Murine Peritoneal Mesothelioma.
    Yurttas C; Beil J; Berchtold S; Smirnow I; Kloker LD; Sipos B; Löffler MW; Königsrainer A; Mihaljevic AL; Lauer UM; Thiel K
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68.
    Ehrig K; Kilinc MO; Chen NG; Stritzker J; Buckel L; Zhang Q; Szalay AA
    J Transl Med; 2013 Mar; 11():79. PubMed ID: 23531320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I Study of Oncolytic Vaccinia Virus GL-ONC1 in Patients with Peritoneal Carcinomatosis.
    Lauer UM; Schell M; Beil J; Berchtold S; Koppenhöfer U; Glatzle J; Königsrainer A; Möhle R; Nann D; Fend F; Pfannenberg C; Bitzer M; Malek NP
    Clin Cancer Res; 2018 Sep; 24(18):4388-4398. PubMed ID: 29773661
    [No Abstract]   [Full Text] [Related]  

  • 8. Tumor vascularization is critical for oncolytic vaccinia virus treatment of peritoneal carcinomatosis.
    Ottolino-Perry K; Tang N; Head R; Ng C; Arulanandam R; Angarita FA; Acuna SA; Chen Y; Bell J; Dacosta RS; McCart JA
    Int J Cancer; 2014 Feb; 134(3):717-30. PubMed ID: 23893655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of the oncolytic virus, CF33, and its derivatives for peritoneal-directed treatment of gastric cancer peritoneal metastases.
    Yang A; Zhang Z; Chaurasiya S; Park AK; Jung A; Lu J; Kim SI; Priceman S; Fong Y; Woo Y
    J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37019471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncolytic vaccinia virus GLV-1h68 exhibits profound antitumoral activities in cell lines originating from neuroendocrine neoplasms.
    Kloker LD; Berchtold S; Smirnow I; Beil J; Krieg A; Sipos B; Lauer UM
    BMC Cancer; 2020 Jul; 20(1):628. PubMed ID: 32631270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging of intratumoral inflammation during oncolytic virotherapy of tumors by 19F-magnetic resonance imaging (MRI).
    Weibel S; Basse-Luesebrink TC; Hess M; Hofmann E; Seubert C; Langbein-Laugwitz J; Gentschev I; Sturm VJ; Ye Y; Kampf T; Jakob PM; Szalay AA
    PLoS One; 2013; 8(2):e56317. PubMed ID: 23441176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel genetically modified oncolytic vaccinia virus in experimental models is effective against a wide range of human cancers.
    Haddad D; Chen N; Zhang Q; Chen CH; Yu YA; Gonzalez L; Aguilar J; Li P; Wong J; Szalay AA; Fong Y
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S665-74. PubMed ID: 22258815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo infection of live tissue with oncolytic viruses.
    Diallo JS; Roy D; Abdelbary H; De Silva N; Bell JC
    J Vis Exp; 2011 Jun; (52):. PubMed ID: 21730946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage response to oncolytic paramyxoviruses potentiates virus-mediated tumor cell killing.
    Tan DQ; Zhang L; Ohba K; Ye M; Ichiyama K; Yamamoto N
    Eur J Immunol; 2016 Apr; 46(4):919-28. PubMed ID: 26763072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine Virus.
    Scheubeck G; Berchtold S; Smirnow I; Schenk A; Beil J; Lauer UM
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31284426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncolytic activity of a coxsackievirus B3 strain in human endometrial cancer cell lines.
    Lin Y; Wang W; Wan J; Yang Y; Fu W; Pan D; Cai L; Cheng T; Huang X; Wang Y
    Virol J; 2018 Apr; 15(1):65. PubMed ID: 29631630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of human prostate tumors and metastases in nude mice following treatment with the recombinant oncolytic vaccinia virus GLV-1h68.
    Gentschev I; Donat U; Hofmann E; Weibel S; Adelfinger M; Raab V; Heisig M; Chen N; Yu YA; Stritzker J; Szalay AA
    J Biomed Biotechnol; 2010; 2010():489759. PubMed ID: 20379368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice.
    Chen NG; Yu YA; Zhang Q; Szalay AA
    J Transl Med; 2011 Sep; 9():164. PubMed ID: 21951588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers.
    Draganov DD; Santidrian AF; Minev I; Nguyen D; Kilinc MO; Petrov I; Vyalkova A; Lander E; Berman M; Minev B; Szalay AA
    J Transl Med; 2019 Mar; 17(1):100. PubMed ID: 30917829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virotherapy of canine tumors with oncolytic vaccinia virus GLV-1h109 expressing an anti-VEGF single-chain antibody.
    Patil SS; Gentschev I; Adelfinger M; Donat U; Hess M; Weibel S; Nolte I; Frentzen A; Szalay AA
    PLoS One; 2012; 7(10):e47472. PubMed ID: 23091626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.